Literature DB >> 6693405

The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.

M N Blackburn, R L Smith, J Carson, C C Sibley.   

Abstract

Chemical modification of a single tryptophan residue in antithrombin III with dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium bromide blocks heparin binding and the heparin-enhanced inhibition of thrombin without altering the heparin-independent rate of thrombin inhibition (Blackburn, M. N., and Sibley, C. C. (1980) J. Biol. Chem. 255, 824-826). The labeled protein was reduced and carboxymethylated and then cleaved with cyanogen bromide. The peptide containing the hydroxynitrobenzyl-labeled tryptophan was isolated by gel filtration and ion exchange chromatography. Amino acid analysis of the labeled peptide indicates that it corresponds to residues 21 through 89 of human antithrombin III. The site of labeling corresponds to Trp 49, which is located within the disulfide-stabilized loops near the NH2-terminal end of the antithrombin III molecule.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693405

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Pleiotropic effects of antithrombin strand 1C substitution mutations.

Authors:  D A Lane; R J Olds; J Conard; M Boisclair; S C Bock; M Hultin; U Abildgaard; H Ireland; E Thompson; G Sas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein.

Authors:  L M Chen; L Chao; R K Mayfield; J Chao
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

3.  A fragment of antithrombin that binds both heparin and thrombin.

Authors:  L Rosenfeld; I Danishefsky
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

4.  Re-formation of disulphide bonds in reduced antithrombin III.

Authors:  X J Sun; J Y Chang
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

Review 5.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

6.  The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.

Authors:  R C Austin; W P Sheffield; R A Rachubinski; M A Blajchman
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

7.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

8.  The complete amino acid sequence of bovine antithrombin (ATIII).

Authors:  H Mejdoub; M Le Ret; Y Boulanger; M Maman; J Choay; J Reinbolt
Journal:  J Protein Chem       Date:  1991-04

9.  Expression of functionally active human antithrombin III.

Authors:  A W Stephens; A Siddiqui; C H Hirs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog.

Authors:  Younan Chen; Weidong Tan; Shengfang Qin; Jie Zhang; Hong Bu; Youping Li; Yanrong Lu; Jingqiu Cheng
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.